Last reviewed · How we verify
NCT05961956
Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
Phase 1, PHASE2 trial testing NVDX3 in Degenerative Lumbar Spondylolisthesis in 5 participants. Participants enrolled and being followed up; not accepting new ones.
18 April 2026
Quick facts
| Lead sponsor | Novadip Biosciences |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 5 |
| Start date | 12 October 2023 |
| Primary completion | 18 April 2026 |
| Estimated completion | 18 April 2026 |
| Sites | 1 location across Luxembourg |
Drugs / interventions tested
- NVDX3 — full drug profile →
Conditions studied
- Degenerative Lumbar Spondylolisthesis — all drugs for Degenerative Lumbar Spondylolisthesis →
Sponsor
Novadip Biosciences — full company profile →
Who can join
Adults 18 to 80, any sex, with Degenerative Lumbar Spondylolisthesis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective, single arm, single-center clinical study to test NVDX3 in patients suffering from low grade one level degenerative lumbar (L1 - S1) spondylolisthesis. NVDX3 will be implanted during a single surgical intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05961956
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NVDX3
Trials testing the same drug.
- NCT05987033 — Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures. · Phase 1, PHASE2 · completed
Other recruiting trials for Degenerative Lumbar Spondylolisthesis
Currently open trials in the same condition.
- NCT06407063 — Long-term Reoperations After Lumbar Spinal Stenosis Surgery · recruiting
- NCT03469791 — Degenerative Spondylolisthesis; Micro-decompression vs Decompression + Instrumented Fusion; Long Term Follow up · NA · active not recruiting
Other Novadip Biosciences trials
Trials by the same sponsor.
- NCT05987033 — Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures. · Phase 1, PHASE2 · completed
- NCT06335394 — Prospective Study in Adults Evaluating Safety & Efficacy of NVD003 for Bone Reconstruction to Treat Lower Limb Nonunion · Phase 1, PHASE2 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05961956 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Novadip Biosciences
- Last refreshed: 24 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05961956.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing